Genmab and GSK seek US approval of monoclonal antibody

Genmab A/S of Denmark and its partner, GlaxoSmithKline, are asking the US Food and Drug Administration to approve ofatumumab, a fully human monoclonal antibody, for the treatment of patients with chronic lymphocytic leukemia (CLL).